<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Brain Arterial Endothelial Cells</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Mesoderm > Vascular > Endothelium > Arterial</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>CLDN5, NOTCH3, MYH11, EGFL7, EFNB2, HEY2</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Cerebral Arteries, Middle Cerebral Artery, Pial Arteries, penetrating arterioles</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>Alzheimer's Disease, Cerebral Amyloid Angiopathy (CAA), Small Vessel Disease, Ischemic Stroke</td>
</tr>
</table>
Brain arterial endothelial cells form the luminal surface of the cerebral vasculature and represent a critical interface between the circulating blood and the neural tissue. These specialized endothelial cells constitute the primary component of the blood-brain barrier (BBB), regulating the passage of molecules, ions, and cells between the bloodstream and the brain parenchyma. The health and function of arterial endothelial cells are essential for maintaining cerebral homeostasis, and their dysfunction is increasingly recognized as a key contributor to neurodegenerative diseases including Alzheimer's disease and related dementias [@zlokovic2011].
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Brain Arterial Endothelial Cells</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Mesoderm > Vascular > Endothelium > Arterial</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>CLDN5, NOTCH3, MYH11, EGFL7, EFNB2, HEY2</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Cerebral Arteries, Middle Cerebral Artery, Pial Arteries, penetrating arterioles</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>Alzheimer's Disease, Cerebral Amyloid Angiopathy (CAA), Small Vessel Disease, Ischemic Stroke</td>
</tr>
</table>
Brain arterial endothelial cells form the luminal surface of the cerebral vasculature and represent a critical interface between the circulating blood and the neural tissue. These specialized endothelial cells constitute the primary component of the blood-brain barrier (BBB), regulating the passage of molecules, ions, and cells between the bloodstream and the brain parenchyma. The health and function of arterial endothelial cells are essential for maintaining cerebral homeostasis, and their dysfunction is increasingly recognized as a key contributor to neurodegenerative diseases including Alzheimer's disease and related dementias [@zlokovic2011].
The cerebral vasculature consists of a hierarchical network of arteries, arterioles, capillaries, and veins, with each vessel type exhibiting distinct morphological and functional properties. Arterial endothelial cells in the brain differ from their peripheral counterparts in several important respects: they possess tighter intercellular junctions, exhibit reduced transcytosis, and express unique sets of transporters and receptors that collectively restrict peripheral molecules from entering the brain while permitting essential nutrients to cross [@iadecola2017].
Brain Arterial Endothelial Cells are specialized cells lining the arterial vasculature of the brain. These cells are fundamental to the neurovascular unit, interacting closely with pericytes, smooth muscle cells, astrocytes, and neurons to maintain cerebral homeostasis. Unlike endothelial cells in peripheral organs, brain arterial endothelial cells maintain highly restrictive barrier properties that protect the brain from harmful substances while enabling selective passage of necessary nutrients, gases, and signaling molecules [@tajes2014].
The arterial segment of the cerebral vasculature includes large conductance arteries at the base of the brain (including the internal carotid and middle cerebral arteries), pial arteries running on the brain surface, and penetrating arterioles that dive into the brain parenchyma. Each of these segments has distinct hemodynamic properties and plays specific roles in regulating cerebral blood flow and blood-brain barrier function [@ayloo2019].
Tight Junctions: The intercellular junctions between brain endothelial cells are composed of occludin, claudin-5 (CLDN5), and various associated proteins that form continuous belts around endothelial cells, effectively sealing the paracellular pathway. These tight junctions prevent the passive diffusion of hydrophilic molecules and ions while permitting the passage of small lipophilic molecules [@sweeney2018].
Limited Transcytosis: Unlike peripheral endothelial cells, brain arterial endothelial cells exhibit minimal caveolae-mediated transcytosis, further restricting the movement of macromolecules across the barrier. This property is critical for maintaining the brain's unique chemical environment.
Specialized Transport Systems: Brain endothelial cells express a range of polarized transporters that mediate the specific uptake of essential nutrients including glucose (via GLUT1), amino acids, and nucleosides while actively effluxing potentially harmful substances through transporters like P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) [@montagne2017].
Endothelial Dysfunction: AD brains show reduced endothelial nitric oxide production, impaired vasodilatory responses, and increased endothelial cell apoptosis. This dysfunction reduces cerebral blood flow and contributes to hypoperfusion, which is observed early in AD pathogenesis [@wright2022].
Blood-Brain Barrier Breakdown: Postmortem studies of AD brains reveal disrupted tight junctions, increased transcytosis, and reduced expression of barrier-specific proteins. PET studies using dynamic contrast agents demonstrate that BBB permeability is increased in AD patients, particularly in regions affected by amyloid pathology [@cao2010].
Cerebral Amyloid Angiopathy: A subset of AD patients develops cerebral amyloid angiopathy (CAA), in which amyloid-beta (Aβ) deposits in the walls of cerebral blood vessels, including arterial endothelial cells. This deposition damages endothelial cells, compromises BBB integrity, and increases the risk of hemorrhagic stroke [@wisniewski2018].
Lipohyalinosis: Small arteries in SVD show degeneration of the smooth muscle layer and replacement with hyaline material, compromising endothelial support and autoregulatory capacity [@vanveluw2020].
White Matter Hyperintensities: MRI-visible white matter hyperintensities are associated with endothelial dysfunction and reduced cerebral perfusion. The endothelial-mediated breakdown of the blood-brain barrier allows plasma proteins to leak into white matter, contributing to demyelination and axonal loss [gronborg2021].
Anti-inflammatory Agents: Reducing neuroinflammation can protect endothelial cells from inflammatory damage. Minocycline and other anti-inflammatory drugs have shown protective effects in preclinical models.
Antioxidant Treatments: Compounds that reduce oxidative stress (including vitamin E, coenzyme Q10, and N-acetylcysteine) may protect endothelial function, though clinical trials have yielded mixed results.
BBB-Permeabilizing Strategies: Temporarily relaxing the BBB may enhance drug delivery to the brain in AD and other neurodegenerative conditions.
Several animal models are used to study brain arterial endothelial dysfunction:
Transgenic AD Models: APP/PS1 and 3xTg-AD mice show age-dependent BBB dysfunction, reduced cerebral blood flow, and endothelial pathology that parallels human disease.
Cerebral Amyloid Angiopathy Models: APP transgenic mice develop Aβ deposits in cerebral vessels, providing a model for studying CAA-related endothelial dysfunction.
Small Vessel Disease Models: Hypertensive rats and mice with chronic hypoperfusion develop white matter lesions and endothelial dysfunction mimicking human SVD [bless2017].
Circulating and imaging biomarkers of endothelial dysfunction include: